drugset / Trial / NCT06751199
UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The aim is to Investigate the safety and efficacy of Portal vein infusion Allogeneic Human umbilical cord mesenchymal stem cells combined with Allogeneic islet transplantation for the treatment of diabetes
Timeline
- Start
- 2024-12-30
- Primary completion
- 2026-07-30
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | allogeneic islet | Cell therapy | — | Other |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | — | Other |